Related Experiment Video
Updated: Aug 9, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
A childhood asthma severity scale: symptoms, medications, and health care visits
A N Ortega1, K D Belanger, M B Bracken
1Division of Health Policy and Administration, Yale University School of Medicine, New Haven, Connecticut 06520-8034, USA. alexander.ortega@yale.edu
Insights
A new Childhood Asthma Severity (CHAS) scale shows promise for large epidemiologic studies. This validated tool helps assess asthma severity across diverse populations, aiding research and public health efforts.
Area of Science:
- Pediatric Pulmonology
- Epidemiology
- Clinical Assessment
Background:
- Existing childhood asthma severity measures lack validity for large-scale epidemiologic studies.
- A standardized, valid tool is needed to assess asthma severity in diverse pediatric populations.
- Current clinical tools are insufficient for population-based research.
Purpose of the Study:
- To develop and validate the Childhood Asthma Severity (CHAS) scale.
- To assess the clinimetric properties of the CHAS scale.
- To identify differences in asthma indicators by participant characteristics.
Main Methods:
- A prospective cohort study included 897 children under 12 with active asthma.
- Data were collected monthly via home interviews over 12 months.
- The CHAS scale was constructed using dimensions of symptoms, medication use, and healthcare visits.
Main Results:
- The CHAS scale demonstrated sufficient preliminary content, construct, and predictive validity.
- Significant healthcare utilization and medication use disparities were observed based on race, ethnicity, insurance, income, and maternal education.
- Asthma symptom prevalence showed similarities across demographic groups.
Conclusions:
- The CHAS scale is a potentially valuable tool for measuring asthma severity in large epidemiologic studies.
- The CHAS scale exhibits adequate clinimetric properties for research applications.
- Further validation may confirm its utility in diverse populations.
Background:
Although there are current measures to evaluate childhood asthma severity for clinical diagnosis and treatment, there is no standard valid measure to evaluate childhood asthma severity for large-scale epidemiologic studies.
Objectives:
To develop and test a childhood asthma severity scale (CHAS) for clinimetric validity and to determine differences in symptoms, medication use, and health care visits by participant characteristics.
Methods:
Eight hundred ninety-seven actively asthmatic children under the age of 12 years were selected from a general population of children. Children were selected from a screening questionnaire administered at six Connecticut hospitals that serve large minority populations in Bridgeport, New Haven, Hartford, and Danbury and one hospital serving south central Massachusetts. Twelve-month baseline data for a prospective cohort study of childhood asthma severity were collected on a monthly basis through home interviews. Home interviews addressed questions on daily symptoms, medication use, and health care visits. A severity scale was constructed using three dimensions: symptoms, medication use, and health care visits.
Results:
CHAS has sufficient preliminary content, construct, and predictive validity. Despite similarities in symptoms, there were health care utilization and medication differentials according to race and ethnicity, insurance status, family income, and maternal education.
Conclusions:
CHAS is a potentially useful measure of asthma severity for large-scale epidemiologic studies. It seems that CHAS has sufficient clinimetric properties.
Related Concept Videos
Asthma-I: Introduction
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...
Asthma I: Introduction
Asthma III: Clinical Manifestations

